Granules India Received ANDA Approval For Losartan And Hydrochlorothiazide Tablets

Granules India Received ANDA Approval For Losartan And Hydrochlorothiazide Tablets

Losartan potassium and hydrochlorothiazide tablets are indicated for the treatment of hypertension to lower blood pressure and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.

FPJ Web DeskUpdated: Saturday, September 30, 2023, 12:50 PM IST
article-image
Granules India Received ANDA Approval For Losartan And Hydrochlorothiazide Tablets | Image: Granules India (Representative)

Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg, 100 mg/12.5 mg, and 100 mg/25 mg. It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Hyzaar Tablets of Organon LLC.

Losartan potassium and hydrochlorothiazide tablets are indicated for the treatment of hypertension to lower blood pressure and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.

Granules now have a total of 60 ANDA approvals from US FDA (58 Final approvals and 2 tentative approvals).

The current annual U.S. market for Losartan and Hydrochlorothiazide Tablets is approximately $73 Million, according to MAT Jul 2023, IQVIA/IMS Health.

Granules India Limited shares

The shares of Granules India Limited on Friday at 3:30pm closed at Rs 355.05, up by 3.86 percent.

RECENT STORIES

Finance Minister Nirmala Sitharaman Announces Collateral-Free Loans Of Up To ₹100 Crore For MSMEs

Finance Minister Nirmala Sitharaman Announces Collateral-Free Loans Of Up To ₹100 Crore For MSMEs

'Putting India On India’s Map': Comedian Kunal Kamra Takes A Dig At Ola Electric; Here's How...

'Putting India On India’s Map': Comedian Kunal Kamra Takes A Dig At Ola Electric; Here's How...

Singapore Police, Banks Work Together To Prevent 1,338 Scams And Avert SGD 53 Million Losses During...

Singapore Police, Banks Work Together To Prevent 1,338 Scams And Avert SGD 53 Million Losses During...

Divi's Laboratories Q2FY25 Consolidated Profit Surges By 51.5% YoY; Income Jumps 35% To ₹2,637.9...

Divi's Laboratories Q2FY25 Consolidated Profit Surges By 51.5% YoY; Income Jumps 35% To ₹2,637.9...

Medtech Leaders Welcome Govt's Move To Launch ₹500 Crore Scheme For Medical Devices

Medtech Leaders Welcome Govt's Move To Launch ₹500 Crore Scheme For Medical Devices